Cite
HARVARD Citation
Lefebvre, P. et al. (n.d.). Real-world evaluation of weight loss in patients with T2DM treated with canagliflozin (CANA) – An electronic health-record (EHR)-based study. Diabetes research and clinical practice. pp. S118-S119. [Online].